Mr Mitchell Wells Managing Director Mr Mitchell Wells is an experienced senior executive and a qualified lawyer with commerical and legal experience in Australia, the United States of America and the United Kingdom. He has served as a director and worked as a senior executive of listed-public and private companies including ASX and Nasdaq listed […]
Dr Sherif Boulos Clinical Research Manager PhD Sherif is tasked with identifying and co-ordinating clinical studies in which Resonance Health’s products can add value. With a focus on HepaFat-Scan and our developing liver fibrosis technology, his work has already led to a number of new and important studies in the NAFLD/NASH and diabetes fields. Prior
Assoc. Prof. Michael House Scientific Research Officer PhD Research Associate Professor Michael House is a biophysicist in the School of Physics at The University of Western Australia and a Scientific Research Officer at Resonance Health. He has extensive experience in quantitative magnetic resonance imaging (MRI) techniques to non-invasively assess human diseases including Alzheimer’s disease, liver
Dr Wenjie Pang Technical & Research Manager PhD Wenjie hails from China, where he enjoyed a successful career researching magnetism in different forms. He came to the University of Western Australia as a visiting research fellow in the Department of Physics. Following an International Scholarship to study for his PhD and some time at the
Resonance Health is an Australian healthcare company specialising in the development and delivery of non-invasive medical imaging software and services. Our products are used by clinicians in the diagnosis and management of human diseases and by pharmaceutical companies in their clinical trials. Resonance Health has gained endorsement by leading physicians worldwide for consistently providing high
Resonance Health provides FerriScan®, Cardiac T2* and HepaFat-Scan® via a unique service model. All patient MRI data is securely transferred to Resonance Health’s central Service Centre where it is analysed by our team of experts and a patient report is returned. Service Model A patient requiring a FerriScan, Cardiac T2* or HepaFat Scan is referred
Quality Assured Service Delivery Read More »
Mr Nick Allan Chief Financial Officer and Company Secretary Mr Nick Allan has over 25 years experience in commerce, corporate finance, accounting, information technology, corporate advisory and public practice. After obtaining a Bachelor of Commerece from the University of Western Australia, Mr Allan qualified as a Chartered Accountant in the UK with Coopers & Lybrand,
Dr Travis Baroni Non Executive Director Dr Travis Baroni has broad experience across industrial research, commercialisation of technology, asset valuations, and investment banking services. He has managed innovation development and technology strategy in a large company setting as well as being an active investor in early stage investments. He has worked in investment banking, providing
Mr Simon Panton Non Executive Director Mr Panton has been a major shareholder of Resonance Health since 2008 and joined the board in 2009, as he is strong believer in liver health technologies. Mr Panton started and ran his own successful small business for over 15 years and brings skills in business and marketing. He
Dr Martin Blake Chairman MBBS, FRANZCR, FAANMS, MBA, FAICD Dr Blake is a Radiologist and Nuclear Physician and brings a wealth of technical and industry experience to Resonance Health. He has been a partner of Perth Radiological Clinic since 1997 and is currently the Chairman of the company. Dr Blake additionally held the position of
INVESTORS
SUPPORT
PATIENTS
PHYSICIANS